Stay updated with breaking news from Genscript Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genscript Biotech Co. (OTCMKTS:GNNSF – Get Rating) was the target of a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 5,524,500 shares, a growth of 31.8% from the April 15th total of 4,192,500 shares. Based on an average daily trading volume, of 2,900 shares, […]
/PRNewswire/ -- The CRISPR technology market size is forecasted to increase by USD 2.88 billion from 2021 to 2026, at a CAGR of 19.34%, according to a recent...
Enzymatic DNA synthesis is a well-established technique of DNA synthesis, which is useful in synthetic biology, genetic engineering, therapeutic antibody...
/PRNewswire/ -- The "Synthetic Biology Market?by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Genome Engineering, Bioinformatics),...
Dublin, Feb. 15, 2023 (GLOBE NEWSWIRE) -- The "Synthetic Biology Market?by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Genome...